L. Sutherland

Heterogeneity of chemosensitivity in human breast carcinoma: use of an adenosine triphosphate (ATP) chemiluminescence assay.

I. Cree, J. Dewar, R. Wood, 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity.

I. Cree, D. Lane, P. Andreotti, 1994, Biochemical and biophysical research communications.

Cytotoxic Action of Heregulin-Granulosa Cell Tumors Express erbB 4 and Are Sensitive to the Updated Version

Robert, R. Daly, D. Quinn, 2006 .

Correlation of the clinical response to chemotherapy in breast cancer with ex vivo chemosensitivity

I. Cree, M. Untch, J. Dewar, 1996, Anti-cancer drugs.

Comparison of MTT and ATP-based assays for the measurement of viable cell number.

I. Cree, R. Petty, R D Petty, 1995, Journal of bioluminescence and chemiluminescence.

The influence of storage on cytotoxic drug activity in an ATP-based chemosensitivity assay.

I. Cree, P. Andreotti, E. Hunter, 1994, Anti-cancer drugs.

Methotrexate chemosensitivity by ATP luminescence in human leukemia cell lines and in breast cancer primary cultures: comparison of the TCA-100 assay with a clonogenic assay.

I. Cree, M. Pazzagli, P. Andreotti, 1995, Anti-cancer drugs.